Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.379 +0.099 (+7.76%)
Streaming Delayed Price Updated: 2:01 PM EDT, Sep 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
Gapping stocks in Wednesday's session ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday's pre-market session. The company's market cap stands at $8.2 million. China SXT Pharmaceuticals... 
Via Benzinga
Discover the top movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
On Thursday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
What's Driving InMed's (INM) 22% After-Hours Surge? ↗
InMed shares jumped 22% in after-hours trading after the company reported encouraging large-animal study results for its Alzheimer's drug candidate INM-901. 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data ↗
Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge during regular market hours. 
Via Benzinga
News headline image
Here are the top movers in Tuesday's session. ↗
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
Curious about the most active stocks on Tuesday? ↗
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
Via Chartmill
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Looking for insights into the US markets in the middle of the day on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Which stocks are gapping on Tuesday? ↗
The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge ↗
InMed stock jumped after preclinical data showed INM-901 lowered brain inflammation tied to Alzheimer's and improved cognitive function in models. 
Via Benzinga
News headline image
Tuesday's pre-market session: top gainers and losers ↗
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Monday? ↗
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise ↗
The positive trial results propelled InMed into the top 25 trending stocks on Stocktwits, with a flood of bullish comments on the platform. 
Via Stocktwits
News headline image
Crude Oil Down 2%; D.R. Horton Earnings Top Views ↗
 
Via Benzinga
News headline image
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing ↗
InMed Pharmaceuticals shares are trading higher by 45% during Tuesday's session. The company announced that INM-901 reduced Alzheimer 's-related inflammation in a preclinical study. 
Via Benzinga
News headline image
Dow Jumps 200 Points; 3M Posts Upbeat Q4 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings ↗
 
Via Benzinga
News headline image
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
InMed Pharmaceuticals Advances Oral Candidate For Alzheimer's Disease, Stock Surges On Tuesday ↗
InMed Pharmaceuticals advances INM-901 as an oral treatment for Alzheimer's. Preclinical studies show the small molecule drug achieves effective brain levels, offering a promising alternative to... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.